ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W905. A total of 6 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,684 | -3.0% | 255,800 | +37.5% | 0.00% | 0.0% |
| Q2 2023 | $258,540 | -61.9% | 186,000 | -56.4% | 0.00% | -50.0% |
| Q1 2023 | $677,976 | -86.3% | 426,400 | -46.3% | 0.00% | -83.3% |
| Q4 2022 | $4,946,620 | +2.5% | 794,000 | +10.2% | 0.01% | +33.3% |
| Q3 2022 | $4,825,000 | +6.9% | 720,200 | +1.5% | 0.01% | +28.6% |
| Q2 2022 | $4,512,000 | +97.3% | 709,500 | +43.9% | 0.01% | +250.0% |
| Q1 2022 | $2,287,000 | -2.0% | 492,900 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $2,333,000 | +154.7% | 466,500 | +513.8% | 0.00% | +100.0% |
| Q3 2021 | $916,000 | -11.8% | 76,000 | +54.8% | 0.00% | 0.0% |
| Q2 2021 | $1,038,000 | -53.1% | 49,100 | -37.8% | 0.00% | -66.7% |
| Q1 2021 | $2,213,000 | +40.7% | 78,900 | +30.4% | 0.00% | 0.0% |
| Q4 2020 | $1,573,000 | +24.8% | 60,500 | +78.5% | 0.00% | -25.0% |
| Q3 2020 | $1,260,000 | -17.6% | 33,900 | +13.8% | 0.00% | -42.9% |
| Q2 2020 | $1,529,000 | +13.6% | 29,800 | -30.2% | 0.01% | -36.4% |
| Q1 2020 | $1,346,000 | -21.3% | 42,700 | +48.8% | 0.01% | -8.3% |
| Q4 2019 | $1,711,000 | +282.8% | 28,700 | +135.2% | 0.01% | +200.0% |
| Q3 2019 | $447,000 | +33.4% | 12,200 | +69.4% | 0.00% | +33.3% |
| Q2 2019 | $335,000 | +34.5% | 7,200 | +16.1% | 0.00% | 0.0% |
| Q1 2019 | $249,000 | -91.8% | 6,200 | -90.6% | 0.00% | -88.5% |
| Q4 2018 | $3,036,000 | +173.8% | 66,000 | +164.0% | 0.03% | +188.9% |
| Q3 2018 | $1,109,000 | +18.4% | 25,000 | +4.6% | 0.01% | +12.5% |
| Q2 2018 | $937,000 | -80.8% | 23,900 | -64.6% | 0.01% | -83.7% |
| Q1 2018 | $4,890,000 | +257.2% | 67,600 | +225.0% | 0.05% | +390.0% |
| Q4 2017 | $1,369,000 | +30.0% | 20,800 | -1.0% | 0.01% | 0.0% |
| Q3 2017 | $1,053,000 | -59.8% | 21,000 | -62.9% | 0.01% | -63.0% |
| Q2 2017 | $2,619,000 | +226.6% | 56,600 | +149.3% | 0.03% | +200.0% |
| Q1 2017 | $802,000 | +80100.0% | 22,700 | +22600.0% | 0.01% | – |
| Q4 2016 | $1,000 | -99.9% | 100 | -99.8% | 0.00% | -100.0% |
| Q3 2016 | $877,000 | +5381.2% | 63,300 | +3856.2% | 0.01% | – |
| Q2 2016 | $16,000 | +700.0% | 1,600 | +1500.0% | 0.00% | – |
| Q1 2016 | $2,000 | -99.7% | 100 | -99.7% | 0.00% | -100.0% |
| Q4 2015 | $657,000 | -69.0% | 29,500 | -67.2% | 0.01% | -72.4% |
| Q3 2015 | $2,121,000 | -27.9% | 89,900 | +149.7% | 0.03% | -29.3% |
| Q2 2015 | $2,943,000 | +217.8% | 36,000 | +260.0% | 0.04% | +173.3% |
| Q1 2015 | $926,000 | +146.3% | 10,000 | +7.5% | 0.02% | +150.0% |
| Q4 2014 | $376,000 | – | 9,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 709,500 | $4,512,000 | 0.01% |
| SIMPLEX TRADING, LLC | 426,100 | $2,709,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 113,600 | $722,000 | 0.00% |